Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
about
Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genomePersistent viremia by a novel parvovirus in a slow loris (Nycticebus coucang) with diffuse histiocytic sarcomaX-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus.Antigens and DNA of a chimpanzee agent related to Epstein-Barr virusSequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genesEpstein-barr virus sequence variation-biology and diseaseIn vitro transformation of lymphoid cells by Abelson murine leukemia virusA genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release.The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.Structural genomic variation in ischemic stroke.BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cellsNcRNA-microchip analysis: a novel approach to identify differential expression of noncoding RNAsEpstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infantsTyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latencyMeasles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteinsEpstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirusComparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promotersHerpesvirus-lymphoid cell interactions: comparative studies on the biology of herpes simplex virus-induced Fc receptors in B, T, and "null" lymphoid cell linesNew method for large-scale growth; and concentration of the Epstein-Barr viruses.Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes.Steroid resistance in the squirrel monkey: an old subject revisited.Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cellsGlycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infectionEpstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus.Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus.An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.Caspase-1 promotes Epstein-Barr virus replication by targeting the large tegument protein deneddylase to the nucleus of productively infected cells.Epstein-Barr virus mRNAs produced by alternative splicingViral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus.Release of infectious Epstein-Barr virus by transformed marmoset leukocytesEpstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes.Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interferenceEpstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.
P2860
Q21090514-42359496-21F2-4879-8CD7-0BE1C34F5C71Q21131081-F0CCB3D2-7AC4-457F-AAE9-AB032B8AFF0DQ24517035-2ADFA8D9-4906-4D0C-AA59-DAE177950C86Q24631919-24DD74C9-9937-416D-AF16-A5189382CAAEQ24632356-15AF32B6-9C2A-446E-8E3D-71CBF6E53976Q27003183-15573B3A-17F7-4573-A2AF-54A6D859A1F6Q28253258-405E13EB-06E9-4952-B7FE-6AB5D4BCBE29Q28943330-6C792281-D634-4E73-B4A4-6F0169B0FA8CQ30278553-A9357A8D-6396-4851-8274-63F27B1B98FAQ30438901-9175BBFA-9DF3-4337-B640-F7697ACFD218Q30981859-A747421F-FC98-4ABC-82D1-05F0E85219F9Q33328501-A8DADFEE-5D80-4E06-8E90-C4595B86E925Q33734342-56206C63-2D0D-4DD6-8CAD-91F5445C0D28Q33754553-141B440D-66AF-49FC-95C1-6ED6011DA226Q33784647-CA363B59-E68D-4B53-8270-CCC2134825F0Q33785237-1CA31CC7-C9CA-4FF7-AE29-83A8ED1190E5Q33796173-CDAC890D-6A9B-4C92-A13F-7483006DA10BQ33835693-DB26B884-DD3C-46DD-801A-5D86D6D5B33EQ33845947-C4ADE841-3D21-42DD-A512-607A972AF799Q33911648-394470A7-7DF8-4ECF-A930-0A4765C883DCQ34048688-FBFE3A01-FD9A-494B-BA98-15BD4923FC39Q34228526-58B19C82-B940-4228-9A08-DDCB580DD6D7Q34251907-1FE40678-7515-4F08-A11A-55917BA66D28Q34254100-69CF8BC4-0C44-4D0C-8F2E-769B561060DAQ34282728-959CB801-8A94-4F32-B6E6-2C6EC3EAB7BCQ34366291-90B98D37-423E-426E-AC77-203F859ECBDEQ34381037-E5627C73-A1D5-4C3F-B2B9-A6C13110976CQ34386338-0790B0BE-925E-49A5-B891-19919F5B2185Q34540653-EED32AE4-F430-4D93-9E29-16404F0FEC1CQ34731769-7407F42E-B657-494D-B595-BD154D6381C3Q34740920-73253C10-DAD8-4CFD-9066-713A6D04F3FEQ35000168-AFAB9D69-6D20-4912-AED9-EB431C457B79Q35003371-E2AE8B51-C9B9-4C79-AEAD-BFD7F9A4FDF7Q35018053-53D2D21F-E00B-451A-871C-589C074B48FDQ35051384-44B766FA-375C-4A87-A347-DDC4E828427EQ35082213-0BB31CA3-8E73-4E7D-BF7E-EEEA8FDD3A96Q35093948-46E5D4B2-900E-423C-BA65-9AC5106925D3Q35101353-A1EE80A9-5D53-4927-8A26-31F247A8B5C6Q35129086-E149B53E-1144-4F37-BD11-4F43A8F16620Q35237835-F96BA217-12FF-40C4-9653-1C7BB391D483
P2860
Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
description
1972 nî lūn-bûn
@nan
1972 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@ast
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@en
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@nl
type
label
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@ast
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@en
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@nl
prefLabel
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@ast
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@en
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@nl
P2093
P2860
P4510
P356
P1476
Epstein-Barr virus: transforma ...... onkey and marmoset leukocytes.
@en
P2093
P2860
P304
P356
10.1073/PNAS.69.2.383
P407
P577
1972-02-01T00:00:00Z